1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with naloxone in 8 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (naloxone) | Trials (naloxone) | Recent Studies (post-2010) (naloxone) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 20,134 | 1,257 | 3,321 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | naloxone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.043 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0219 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0397 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1896 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0795 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0154 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0089 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esplugues, JV; Pique, JM; Whittle, BJ | 1 |
| Burde, R; Schultz, G; Seifert, R | 1 |
| Imura, Y; Nishikawa, K; Shino, A; Terashita, Z | 1 |
| Ezra, D; Faden, AI; Feuerstein, G; Lux, WE; Snyder, F | 1 |
| Bernard, GR; Weikert, LF | 1 |
| Benowitz, NL; Heller, PH; Levine, JD; Miao, FJ | 1 |
| Buéno, L; Fioramonti, J; Million, M; Zajac, JM | 1 |
| Hou, T; Wu, K; Xiao, J; Zeng, H; Zhao, D | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and naloxone
| Article | Year |
|---|---|
Pharmacotherapy of sepsis.
Topics: Acetylcysteine; Antioxidants; Bradykinin; Cyclooxygenase Inhibitors; Humans; Naloxone; Pentoxifylline; Platelet Activating Factor; Sepsis | 1996 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and naloxone
| Article | Year |
|---|---|
Influence of morphine or capsaicin pretreatment on rat gastric microcirculatory response to PAF.
Topics: Animals; Blood Pressure; Capsaicin; Female; Gastric Mucosa; Male; Microcirculation; Morphine; Naloxone; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reference Values; Regional Blood Flow | 1990 |
Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells.
Topics: Adenosine Triphosphate; Alprostadil; Biotransformation; Endorphins; Enkephalin, Methionine; Humans; In Vitro Techniques; Leukemia, Experimental; Morphine; N-Formylmethionine Leucyl-Phenylalanine; Naloxone; Neutrophils; Oxygen Consumption; Platelet Activating Factor; Superoxides; Tumor Cells, Cultured | 1989 |
A lethal role of platelet activating factor in anaphylactic shock in mice.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chromones; Dexamethasone; Male; Mice; Mice, Inbred Strains; Naloxone; Phospholipid Ethers; Platelet Activating Factor; Pyrazoles; SRS-A; Thiazoles | 1987 |
Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
Topics: Animals; Blood Pressure; Guinea Pigs; Hypotension; Male; Naloxone; Platelet Activating Factor; Thiazolidines; Thyrotropin-Releasing Hormone; Time Factors | 1984 |
Contribution of adrenal hormones to nicotine-induced inhibition of synovial plasma extravasation in the rat.
Topics: Adrenal Glands; Animals; Bradykinin; Capillary Permeability; Male; Mecamylamine; Mifepristone; Naloxone; Nicotine; Platelet Activating Factor; Propanolamines; Rats; Rats, Sprague-Dawley | 1997 |
Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor.
Topics: Animals; Body Temperature; Endotoxins; Gastrointestinal Motility; Male; Myoelectric Complex, Migrating; Naloxone; Narcotic Antagonists; Oligopeptides; Platelet Activating Factor; Rats; Rats, Wistar | 1997 |
Synergetic protective effects of combined blockade by two kinds of autolesion mediator receptor on neurological function after cervical cord injury.
Topics: Animals; Cats; Diterpenes; Drug Synergism; Ginkgolides; Lactones; Male; Naloxone; Narcotic Antagonists; Platelet Activating Factor; Platelet Membrane Glycoproteins; Random Allocation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Spinal Cord; Spinal Cord Injuries | 1998 |